Search Results
Université Lyon 1, Villeurbanne, France
Université de Lyon, Lyon, France
Search for other papers by Filipe de Vadder in
Google Scholar
PubMed
Université Lyon 1, Villeurbanne, France
Université de Lyon, Lyon, France
Search for other papers by Gilles Mithieux in
Google Scholar
PubMed
the hormonal signals that the gut releases in blood in response to nutrient assimilation and which modulate hunger sensations and glucose homeostasis, such as cholecystokinin and glucagon-like peptide 1, a set of processes referred to as the gut–brain
Search for other papers by Silvia Begliuomini in
Google Scholar
PubMed
Search for other papers by Elena Lenzi in
Google Scholar
PubMed
Search for other papers by Filippo Ninni in
Google Scholar
PubMed
Search for other papers by Elena Casarosa in
Google Scholar
PubMed
Search for other papers by Sara Merlini in
Google Scholar
PubMed
Search for other papers by Nicola Pluchino in
Google Scholar
PubMed
Search for other papers by Valeria Valentino in
Google Scholar
PubMed
Search for other papers by Stefano Luisi in
Google Scholar
PubMed
Search for other papers by Michele Luisi in
Google Scholar
PubMed
Search for other papers by Andrea R Genazzani in
Google Scholar
PubMed
Introduction Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family expressed in many areas of the adult mammalian brain. Its biological action is mediated by the specific tyrosine kinase receptor trkB (Tapia Aranciba et al
Search for other papers by Laurent Givalois in
Google Scholar
PubMed
Search for other papers by Gaëlle Naert in
Google Scholar
PubMed
Search for other papers by Lucia Tapia-Arancibia in
Google Scholar
PubMed
Search for other papers by Sandor Arancibia in
Google Scholar
PubMed
Introduction The brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family having the nerve growth factor as prototype. The main biological effects of BDNF are mediated by specific tyrosine kinase (TrkB
Department of Child Health, University of Arizona College of Medicine, Phoenix, Arizona, USA
Search for other papers by J Bryce Ortiz in
Google Scholar
PubMed
Search for other papers by Sebastian Tellez in
Google Scholar
PubMed
Department of Biology and Biochemistry, University of Bath, Bath, United Kingdom
Search for other papers by Giri Rampal in
Google Scholar
PubMed
Search for other papers by Grant S Mannino in
Google Scholar
PubMed
Search for other papers by Nicole Couillard in
Google Scholar
PubMed
Search for other papers by Matias Mendez in
Google Scholar
PubMed
Search for other papers by Tabitha R F Green in
Google Scholar
PubMed
Search for other papers by Sean M Murphy in
Google Scholar
PubMed
Search for other papers by Rachel K Rowe in
Google Scholar
PubMed
Introduction Annually, approximately 70 million people worldwide suffer from a traumatic brain injury (TBI) ( Dewan et al. 2018 ), with 1.5 million of these individuals residing in the USA. Among the 1.5 million, around 50,000–60,000 are
Search for other papers by Marion Walser in
Google Scholar
PubMed
Search for other papers by Linus Schiöler in
Google Scholar
PubMed
Search for other papers by Jan Oscarsson in
Google Scholar
PubMed
Laboratory of Experimental Endocrinology, Department for Public Health and Community Medicine, AstraZeneca R&D, Institute for Neuroscience and Physiology, Department of Primary Health Care, Department of Internal Medicine, The Sahlgrenska Academy, Sahlgrenska University Hospital, University of Gothenburg, Blå Stråket 5, SE-413 45 Gothenburg, Sweden
Search for other papers by Maria A I Åberg in
Google Scholar
PubMed
Search for other papers by Johan Svensson in
Google Scholar
PubMed
Laboratory of Experimental Endocrinology, Department for Public Health and Community Medicine, AstraZeneca R&D, Institute for Neuroscience and Physiology, Department of Primary Health Care, Department of Internal Medicine, The Sahlgrenska Academy, Sahlgrenska University Hospital, University of Gothenburg, Blå Stråket 5, SE-413 45 Gothenburg, Sweden
Search for other papers by N David Åberg in
Google Scholar
PubMed
Search for other papers by Jörgen Isgaard in
Google Scholar
PubMed
-proliferative effects ( Åberg et al . 2009 , 2010 ). The fact that GH-receptors are expressed in both glial cells and neurons ( Lobie et al . 1993 ) and that GH crosses the blood–brain barrier (BBB) ( Lopez-Fernandez et al . 1996 , Ye et al . 1997 ) indicates that
Search for other papers by Helge Müller in
Google Scholar
PubMed
Search for other papers by Juliane Kröger in
Google Scholar
PubMed
Search for other papers by Olaf Jöhren in
Google Scholar
PubMed
Search for other papers by Silke Szymczak in
Google Scholar
PubMed
Search for other papers by Michael Bader in
Google Scholar
PubMed
Search for other papers by Peter Dominiak in
Google Scholar
PubMed
Search for other papers by Walter Raasch in
Google Scholar
PubMed
). We aimed to answer this question in the present study by using the transgenic rats with low brain angiotensinogen (TGR(ASrAOGEN)) ( Schinke et al . 1999 ). In TGR(ASrAOGEN), angiotensinogen protein concentration was reduced to 10% in medulla, pons
Search for other papers by Clive W Coen in
Google Scholar
PubMed
From Galen in the 2nd century AD, medical orthodoxy held that the brain–pituitary axis terminated in the nostrils and palate. Blood was allegedly endowed with vital spirit in the left ventricle of the heart and with animal spirit, the substance
Search for other papers by J Shaik Mohamed in
Google Scholar
PubMed
Search for other papers by I A Khan in
Google Scholar
PubMed
conventional reverse transcription-polymerase chain reaction (RT-PCR) method, which allows detection of only the final amplified product, has been employed to study expression patterns of GnRH mRNAs in discrete brain areas of rainbow trout ( Ferriere et al
Search for other papers by Riccardo Dore in
Google Scholar
PubMed
Search for other papers by Luka Levata in
Google Scholar
PubMed
Search for other papers by Sogol Gachkar in
Google Scholar
PubMed
Search for other papers by Olaf Jöhren in
Google Scholar
PubMed
Search for other papers by Jens Mittag in
Google Scholar
PubMed
Search for other papers by Hendrik Lehnert in
Google Scholar
PubMed
Search for other papers by Carla Schulz in
Google Scholar
PubMed
regulation of energy homeostasis. However, the underlying mechanisms are poorly understood. In the brain, and in agreement with its role in the control of energy balance, NUCB2/nesfatin-1 is highly expressed in several hypothalamic nuclei such as
Search for other papers by M. R. A. CHANCE in
Google Scholar
PubMed
Search for other papers by A. P. WALKER in
Google Scholar
PubMed
SUMMARY
1. Following the demonstration [Chance & Yaxley, 1950] that the brain glycogen of the mouse rises during a convulsion, an attempt has been made to study the effect of various substances on the level of brain glycogen in the mouse both when resting and after a convulsion induced by metrazol. The substances used were glucose, adrenaline, insulin, deoxycorticosterone glucoside, cortisone acetate and the anti-insulin principle of the anterior pituitary. The effect of fasting on the brain glycogen of the resting mouse was also examined.
2. The level of glycogen in the brain rose in the presence of a raised blood sugar or following injection of the anti-insulin principle. Insulin antagonized the effect of the latter without altering the level of the blood sugar.
3. During convulsions induced by metrazol after the administration of insulin, the level of the blood-sugar was reduced, and the usual increment in brain glycogen was suppressed. It reappeared when sufficient glucose was injected to restore the blood-sugar level to normal. None of the other substances tested affected the rise in glycogen level of the brain induced by a convulsion.
4. During certain types of normal behaviour [Chance, 1953 a] the levels of the blood sugar and brain glycogen generally change independently of each other, but on occasion both rise simultaneously. It is concluded that they represent independent responses resulting from central nervous activity.